We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$2.9B
AUM Growth
+$137M
Cap. Flow
+$88.8M
Cap. Flow %
3.06%
Top 10 Hldgs %
17.97%
Holding
1,008
New
71
Increased
442
Reduced
400
Closed
82

Top Buys

Rank Stock Value
1
VGM icon
Invesco Trust Investment Grade Municipals
VGM
+$4.8M
2
NMZ icon
Nuveen Municipal High Income Opportunity Fund
NMZ
+$4.39M
3
MQY icon
BlackRock MuniYield Quality Fund
MQY
+$4.26M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.84M
5
OLMA icon
Olema Pharmaceuticals
OLMA
+$3.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$19.8M
2
ETNB
89bio
ETNB
+$3.65M
3
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$3.59M
4
RKLB icon
Rocket Lab Corp
RKLB
+$3.39M
5
VMO icon
Invesco Municipal Opportunity Trust
VMO
+$3.16M

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 11.66%
3 Financials 9.01%
4 Industrials 7.22%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLE
176
DELISTED
BlackRock Municipal Income Trust II
BLE
$4.22M 0.15%
404,313
-23,532
-6% -$246K
STX icon
177
Seagate
STX
$185B
$4.22M 0.15%
15,312
-8,798
-36% -$2.28M
AIG icon
178
American International
AIG
$40.6B
$4.19M 0.14%
49,015
-9,027
-16% -$722K
FMNY icon
179
First Trust New York Municipal High Income ETF
FMNY
$38.3M
$4.14M 0.14%
155,121
+47,844
+45% +$1.28M
DCO icon
180
Ducommun
DCO
$2.98B
$4.09M 0.14%
42,989
+3,857
+10% +$359K
LHX icon
181
L3Harris
LHX
$53.5B
$4.07M 0.14%
13,867
+1,127
+9% +$326K
TY icon
182
TRI-Continental Corp
TY
$1.9B
$4.04M 0.14%
123,776
+26,593
+27% +$900K
CTAS icon
183
Cintas
CTAS
$82.5B
$4.04M 0.14%
21,458
-7,036
-25% -$1.33M
SLRC icon
184
SLR Investment Corp
SLRC
$705M
$4.03M 0.14%
260,893
-9,613
-4% -$147K
CION icon
185
CION Investment
CION
$376M
$4.01M 0.14%
414,620
-101,156
-20% -$975K
SUPN icon
186
Supernus Pharmaceuticals
SUPN
$2.78B
$4.01M 0.14%
80,651
-21,089
-21% -$1.03M
NUVB icon
187
Nuvation Bio
NUVB
$2.29B
$3.99M 0.14%
445,279
+106,008
+31% +$657K
ASML icon
188
ASML
ASML
$688B
$3.98M 0.14%
3,716
+364
+11% +$380K
NKX icon
189
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$662M
$3.94M 0.14%
316,709
+29,101
+10% +$369K
TMO icon
190
Thermo Fisher Scientific
TMO
$223B
$3.93M 0.14%
6,788
+1,602
+31% +$906K
KTF
191
DWS Municipal Income Trust
KTF
$353M
$3.92M 0.14%
431,210
-30,898
-7% -$283K
FTNT icon
192
Fortinet
FTNT
$119B
$3.88M 0.13%
48,893
-4,751
-9% -$394K
EOT
193
Eaton Vance National Municipal Opportunities Trust
EOT
$272M
$3.87M 0.13%
228,730
-112,358
-33% -$1.88M
SNDX icon
194
Syndax Pharmaceuticals
SNDX
$1.81B
$3.86M 0.13%
183,802
+129,104
+236% +$2.25M
FIX icon
195
Comfort Systems
FIX
$59.5B
$3.83M 0.13%
4,109
+475
+13% +$439K
NI icon
196
NiSource
NI
$20B
$3.83M 0.13%
91,609
+750
+0.8% +$32K
SPY icon
197
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$3.79M 0.13%
5,563
-82
-1% -$55.4K
URGN icon
198
UroGen Pharma
URGN
$2.26B
$3.79M 0.13%
161,924
+96,741
+148% +$2.1M
TVTX icon
199
Travere Therapeutics
TVTX
$5.81B
$3.79M 0.13%
99,229
+62,419
+170% +$2.03M
CRM icon
200
Salesforce
CRM
$162B
$3.75M 0.13%
14,167
-2,219
-14% -$551K
6 7
8
9 10

Similar funds

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return

Hennion & Walsh Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Hennion & Walsh Asset Management held 1,008 positions worth $2.9B, up 5% from $2.76B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management deployed $88.8M of net new capital in Q4 2025, opening 71 new positions and adding to 442 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Rhythm Pharmaceuticals, an estimated $3.59M trimmed.

  • Hennion & Walsh Asset Management's largest Q4 2025 buy was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.
  • Hennion & Walsh Asset Management added most to Invesco Trust Investment Grade Municipals in Q4 2025, an estimated $4.8M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2025 reduction was Rhythm Pharmaceuticals, cutting an estimated $3.59M.
  • Hennion & Walsh Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $19.8M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $2.9B portfolio in Q4 2025.
  • Hennion & Walsh Asset Management opened 71 new positions and closed 82 in Q4 2025.
  • Hennion & Walsh Asset Management's portfolio value rose 5% quarter-over-quarter to $2.9B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2025, filed 14 Jan 2026.